![(R)-2-[(5-Bromo-1H-indol-3-yl)carbonyl]-1-pyrrolidinecarboxylic acid benzyl ester](https://manusakttevabiopharma.com/wp-content/uploads/2021/12/143322-56-9.jpg)
We are offering the product from our Indian manufacturer’s USFDA, Japan PMDA, Korea FDA approved site. Their facility is COFEPRIS inspected for several products. Their R&D facility is recognized by the Department of Scientific and Industrial Research (DSIR, Ministry of Science and Technology, Government of India).
(R)-2-[(5-Bromo-1H-indol-3-yl)carbonyl]-1-pyrrolidinecarboxylic acid benzyl ester
Additional information
| Product Name | (R)-2-[(5-Bromo-1H-indol-3-yl)carbonyl]-1-pyrrolidinecarboxylic acid benzyl ester |
|---|---|
| CAS Registry No | 143322-56-9 |
| Specification | In-House |
| Synonyms | Benzyl (2R)-2-[(5-bromo-1H-indol-3-yl)carbonyl]pyrrolidine-1-carboxylate |
| Molecular Formula | C21H19BrN2O3 |
| Molecular Weight | 427.29 |
| MSDS Description | Available on request |
| Availability | For Research and Development Purpose |
| Application | Anti Migraine |
![1-[4-(Chloromethyl)-1,3-thiazol-2-yl]guanidine hydrochloride (1:1)](https://manusakttevabiopharma.com/wp-content/uploads/2021/12/69014-12-6.jpg)
